Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_assertion type Assertion NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_head.
- NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_assertion description "[The MAL gene, which has been shown to confer resistance to cancer therapy, was most highly overexpressed in short-term survivors (3-fold compared with long-term survivors, and 29-fold compared with early-stage cases).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_provenance.
- NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_assertion evidence source_evidence_literature NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_provenance.
- NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_assertion SIO_000772 15897565 NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_provenance.
- NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_assertion wasDerivedFrom befree-20140225 NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_provenance.
- NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_assertion wasGeneratedBy ECO_0000203 NP914837.RACpEPA86i9Zn5vrQAmfhC6V7pOsD1j9AesEin0qFHLcE130_provenance.